Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum
1 other identifier
observational
46
1 country
1
Brief Summary
Syphilis is an important sexually transmitted infection. There has been an epidemic of syphilis amongst men who have sex with men in the United Kingdom in the last decade. Early infection with syphilis causes a genital ulcer followed, in the absence of treatment, by a generalised illness often accompanied by rash. Studies on the pathogenesis of syphilis have been limited because it is not possible to grow syphilis outside of the body. New approaches using molecular tests allow the immune response of the patient to infection to be measured directly from a swab of a genital ulcer or rash and/or a blood sample and also allow the whole genetic sequence of the bacteria to be obtained from a swab. In this study the investigators will collect swabs from ulcers or rashes and a blood sample from patients with syphilis and measure both the response of the patient immune system and the genetic sequence of the bacteria. Patients will be enrolled at sexual health clinics in the United Kingdom. Patients will receive standard medical care including standard treatment for syphilis in line with national guidelines. Standard management already includes collection of a swab and a blood sample. For this study an additional swab sample and an additional 5ml of blood will be collected for use in this research project. By better understanding host immune system responds to infection with syphilis the studies aims to gain better insights in to the pathogenesis of this important sexually transmitted disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2017
CompletedFirst Posted
Study publicly available on registry
October 16, 2017
CompletedStudy Start
First participant enrolled
October 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedOctober 5, 2023
October 1, 2023
1.8 years
October 11, 2017
October 4, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Whole Genome Sequencing
Whole Genome Sequencing of T.pallidum
From samples collected at baseline
Host Transcriptomic Response
RNA Sequencing from lesion and blood samples
From samples collected at baseline
Interventions
No active intervention is undertaken. Collection of samples for bio-informatic analysis only
Eligibility Criteria
Early infectious syphilis with exudative skin/genital lesions from which a lesion swab can be obtained
You may qualify if:
- Early infectious syphilis with exudative skin/genital lesions from which a lesion swab can be obtained
You may not qualify if:
- Age \<18 years
- Unable to provide consent
- Patients with other stages of syphilis apart from Primary or Secondary OR patients without a lesion from which swabs can be obtained
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mortimer Market Centre
London, WC1E 6JB, United Kingdom
Biospecimen
Blood and Lesion Swab samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2017
First Posted
October 16, 2017
Study Start
October 27, 2017
Primary Completion
July 30, 2019
Study Completion
August 1, 2024
Last Updated
October 5, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share